Estrella Immunopharma ESLA
NASDAQ ESLA
$0.69 +0.14 (+25.45%)
As of: Oct 22, 2026 · 1:18 PM EDT

Estrella Immunopharma (ESLA) EV to CFO (2025 - 2026)

Updated

Analysis

Estrella Immunopharma (ESLA) EV to CFO (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn
10 Estrella Immunopharma 29.88 Mn 24.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.65
Dec 31, 2025 5.90
Mar 31, 2025 5.78
API Access

Estrella Immunopharma EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ESLA&period=max&api_key=YOUR_API_KEY